Moat Biotechnology
Latest round
- Series C
Last raised
- Jun 2022
Total raised
- Undisclosed
Investors
- 1
About Moat Biotechnology
Based in Oklahoma, US, and founded in 2022, Moat Biotechnology is a biopharmaceutical company focused on the development of novel intranasal and oral vaccines. As of 2023, the company is headed by its CEO Dr. Scott Rollins, who also co-founded the firm. The company develops intranasal and oral vaccines based on the SC-AdVax platform which is licensed from the Mayo Clinic. The firm offerings help in mucosal and systemic immunity for the treatment of viruses and infectious diseases.
Who invested in Moat Biotechnology
1 investor across 2 rounds
See all investors in Moat Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Moat Biotechnology
Who invested in Moat Biotechnology?
Moat Biotechnology has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Moat Biotechnology raised?
Moat Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Moat Biotechnology last raise money?
Moat Biotechnology's most recent round on record is a Series C, in Jun 2022.
What does Moat Biotechnology do?
Based in Oklahoma, US, and founded in 2022, Moat Biotechnology is a biopharmaceutical company focused on the development of novel intranasal and oral vaccines.
Where is Moat Biotechnology headquartered?
Moat Biotechnology is headquartered in Oklahoma City, US.
Which VCs invest in companies like Moat Biotechnology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Moat Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Moat Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.